BDRX
Price
$2.09
Change
-$0.20 (-8.73%)
Updated
Jan 14 closing price
Capitalization
1.74M
Intraday BUY SELL Signals
GDTC
Price
$0.94
Change
-$0.28 (-22.95%)
Updated
Jan 14 closing price
Capitalization
11.01M
109 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BDRX vs GDTC

Header iconBDRX vs GDTC Comparison
Open Charts BDRX vs GDTCBanner chart's image
Biodexa Pharmaceuticals
Price$2.09
Change-$0.20 (-8.73%)
Volume$126.29K
Capitalization1.74M
CytoMed Therapeutics
Price$0.94
Change-$0.28 (-22.95%)
Volume$147.03K
Capitalization11.01M
BDRX vs GDTC Comparison Chart in %
BDRX
Daily Signal:
Gain/Loss:
GDTC
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BDRX vs. GDTC commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDRX is a Hold and GDTC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (BDRX: $2.09 vs. GDTC: $0.94)
Brand notoriety: BDRX and GDTC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BDRX: 10% vs. GDTC: 269%
Market capitalization -- BDRX: $1.74M vs. GDTC: $11.01M
BDRX [@Biotechnology] is valued at $1.74M. GDTC’s [@Biotechnology] market capitalization is $11.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BDRX’s FA Score shows that 1 FA rating(s) are green whileGDTC’s FA Score has 0 green FA rating(s).

  • BDRX’s FA Score: 1 green, 4 red.
  • GDTC’s FA Score: 0 green, 5 red.
According to our system of comparison, both BDRX and GDTC are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BDRX’s TA Score shows that 3 TA indicator(s) are bullish while GDTC’s TA Score has 3 bullish TA indicator(s).

  • BDRX’s TA Score: 3 bullish, 6 bearish.
  • GDTC’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, GDTC is a better buy in the short-term than BDRX.

Price Growth

BDRX (@Biotechnology) experienced а -13.64% price change this week, while GDTC (@Biotechnology) price change was -32.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.47%. For the same industry, the average monthly price growth was +3.44%, and the average quarterly price growth was +44.89%.

Reported Earning Dates

GDTC is expected to report earnings on May 04, 2026.

Industries' Descriptions

@Biotechnology (+0.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GDTC($11M) has a higher market cap than BDRX($1.74M). BDRX YTD gains are higher at: -7.930 vs. GDTC (-29.955).
BDRXGDTCBDRX / GDTC
Capitalization1.74M11M16%
EBITDA-5.56MN/A-
Gain YTD-7.930-29.95526%
P/E RatioN/AN/A-
Revenue0N/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
BDRX: Fundamental Ratings
BDRX
OUTLOOK RATING
1..100
85
VALUATION
overvalued / fair valued / undervalued
1..100
26
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
98
P/E GROWTH RATING
1..100
95
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BDRXGDTC
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 7 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 10 days ago
75%
N/A
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
83%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
BDRX
Daily Signal:
Gain/Loss:
GDTC
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LZM5.840.34
+6.18%
Lifezone Metals Limited
MYPS0.620.02
+3.65%
PLAYSTUDIOS
HLI182.602.03
+1.12%
Houlihan Lokey
SDRL35.280.01
+0.03%
Seadrill Limited
BJDX0.65-0.01
-0.90%
Bluejay Diagnostics Inc

BDRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BDRX has been loosely correlated with LVTX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if BDRX jumps, then LVTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDRX
1D Price
Change %
BDRX100%
-8.73%
LVTX - BDRX
41%
Loosely correlated
N/A
SCNI - BDRX
32%
Poorly correlated
+15.59%
PRQR - BDRX
32%
Poorly correlated
N/A
AVTX - BDRX
32%
Poorly correlated
-5.87%
KRRO - BDRX
31%
Poorly correlated
+0.11%
More

GDTC and

Correlation & Price change

A.I.dvisor indicates that over the last year, GDTC has been loosely correlated with CYCN. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if GDTC jumps, then CYCN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GDTC
1D Price
Change %
GDTC100%
-23.35%
CYCN - GDTC
35%
Loosely correlated
-0.65%
CVKD - GDTC
29%
Poorly correlated
-3.11%
RPRX - GDTC
29%
Poorly correlated
-0.37%
QSI - GDTC
28%
Poorly correlated
N/A
BDRX - GDTC
27%
Poorly correlated
-8.73%
More